CD40LG and prostate cancer: The percent of IgG and IgM antibodies within the entire pool of antibodies were not determined, neither were antibody titers, however, we did find this system of detecting M. hyorhinis antibodies to be reliable and simple, thus allowing further evaluation of this assay in subjects with prostate cancer.